← Leaderboard
WBA
Ticker
WBA
Congressional Trades
19
by 5 members
Ticker Intelligence Brief
Who in Congress traded WBA, when, and what happened after?
A ticker-first view for retail/data users: latest disclosure, largest range, disclosure lag, party flow, contracts, lobbying, and source-linked receipts.
Latest receipt
Valerie Hoyle
SELL · 2025-08-27
Largest range
$50K – $100K
Tommy Tuberville
Slowest filing
112d
Tommy Tuberville
Best vs SPY
19.4%
Julie Johnson
Buys
10
53%
Sells
9
47%
Total Volume
$360K
midpoint
Unique Traders
5
members
Party Breakdown
Democrats10 · 53%
Republicans9 · 47%
Party Trading Divergence
Democrat vs. Republican buy / sell pressure by monthHIGH DIVERGENCEBar length = total trades. Color = net sentiment — green = net buying, red = net selling. Months with no activity hidden.
Democrat ←
Month
→ Republican
—
May '23
1▲
—
Jun '23
2▲
—
Jul '23
1▲
0▲2▼
Mar '24⚡
2▲
—
Apr '24
0▲2▼
1▲
Jul '24
—
1▲
Aug '24
—
1▲
Jan '25
—
0▲3▼
Feb '25
—
0▲2▼
Aug '25
—
Democrats3▲7▼Net sellers
vs
Republicans6▲2▼Net buyers
Net buyingNet selling⚡ Party split
💼 Lobbying Filings
all →- 2026-04-20$0WALGREENS CO.
- 2026-04-19$50KWALGREENS CO.Issues related to pharmacies, pharmacists, Medicare reimbursement, and opioids; Issues related to vaccines; Issues related to the FDA certification process; Issues related to Pharmacy Benefit Managers. Issues related to pharmacies, pharmacists, and Medicare reimbursement; Issues related to the implementation of the Inflation Reduction Act of 2022 (P.L. 117-169); Issues related to Pharmacy Benefit Managers. Issues related to corporate tax, net operating loss, EBITA/EBIDA.
- 2026-01-20$0WALGREENS CO.
- 2026-01-19$50KWALGREENS CO.Issues related to pharmacies, pharmacists, Medicare reimbursement, and opioids; Issues related to vaccines; Issues related to the FDA certification process; Issues related to Pharmacy Benefit Managers. Issues related to pharmacies, pharmacists, and Medicare reimbursement; Issues related to the implementation of the Inflation Reduction Act of 2022 (P.L. 117-169); Issues related to Pharmacy Benefit Managers. Issues related to corporate tax, net operating loss, EBITA/EBIDA.
- 2025-10-20$0WALGREENS CO.
- 2025-10-18$50KWALGREENS CO.Issues related to pharmacies, pharmacists, Medicare reimbursement, and opioids; Issues related to vaccines; Issues related to the FDA certification process; Issues related to Pharmacy Benefit Managers. Issues related to pharmacies, pharmacists, and Medicare reimbursement; Issues related to the implementation of the Inflation Reduction Act of 2022 (P.L. 117-169); Issues related to Pharmacy Benefit Managers. Issues related to corporate tax, net operating loss, EBITA/EBIDA.
- 2025-07-21$0WALGREENS CO.
- 2025-07-18$50KWALGREENS CO.Issues related to pharmacies, pharmacists, Medicare reimbursement, and opioids; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to FDA certification process; Issues related to Pharmacy Benefit Managers. Issues related to pharmacies, pharmacists, and Medicare reimbursement; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Pharmacy Benefit Managers. Issues related to corporate tax, net operating loss, EBITA/EBIDA.
- 2025-04-21$0WALGREENS CO.
- 2025-04-16$50KWALGREENS CO.Issues related to pharmacies, pharmacists, Medicare reimbursement, and opioids; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to FDA certification process; Issues related to Pharmacy Benefit Managers. Issues related to pharmacies, pharmacists, and Medicare reimbursement; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Pharmacy Benefit Managers. Issues related to corporate tax, net operating loss, EBITA/EBIDA.
Congressional Momentum
buy vs. sell pressureNEUTRALScore 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.
Last 30 Days
No trades
Last 90 Days
No trades
All-Time
–43
10 buys19 total9 sells
$154K buys · $206K sells
Cumulative Net Position (buy vol − sell vol)
-$52K
2022-0119 trades plotted2025-08
Best Timers
avg excess return vs SPY · WBA trades only5 members w/ alpha dataExcess return = stock price change minus SPY change over the same holding window.Congress avg: -20.4%· 20% of traders beat SPY on this name
Top Alpha Generators
D:4R:1House:4Senate:1
underperformed SPY|beat SPY
Worst Timers
bottom 5 by avg excess return
underperformed SPY|beat SPY
Worst single trade: Ro Khanna (-67.1%)Best single trade: Julie Johnson (+19.4%)
Timing Fingerprint
filing delay vs. excess return over SPY · 10 tradesCongress avg -28.7% vs SPYEach dot = one disclosed trade. X-axis = days between trade and STOCK Act filing.Y-axis = return above (or below) SPY over the subsequent holding window. Upper-right = late filers who beat the market.
10% of trades beat SPYavg excess -28.7%avg delay 22d4 buys6 sellsBuySellOther· dot size ∝ trade size
Trade Activity Timeline
Congressional buys & sells by month · last 11 months w/ activity
22/01
23/05
23/06
23/07
24/03
24/04
24/07
24/08
25/01
25/02
25/08
BuysSellsOtherHigh-volume month
Who Moved First
each row = one member · sorted by earliest disclosed trade3 buyers ·5 sellers
BuySellOtherDot size ∝ trade size · top 5 most-active traders shown
Seasonal Rhythm
Congress buy/sell pressure by month & yearEach cell = one calendar month. Green = net Congress buying, red = net selling. Intensity ∝ consensus strength. Hover for details.
Net buyingNet sellingNo trades · number = trade count
Peak buy month: Jan · Peak sell month: Feb
Congressional Conviction Timeline
net positioning · alpha track recordMIXED10 buys9 sellscumulative α -111.4%11mo tracked
Monthly Net Flow (Buys − Sells)
Cumulative Excess Return on Congressional Buys vs SPY
All Disclosed Trades
| Date | Member | Action | Amount | Filing Delay | Receipt |
|---|---|---|---|---|---|
| 2025-08-27 | DValerie Hoyle | SELL | $1K – $15K | 19d | receipt → |
| 2025-08-27 | DValerie Hoyle | SELL | $1K – $15K | 16d | receipt → |
| 2025-02-12 | DJulie Johnson | SELL | $1K – $15K | 28d | receipt → |
| 2025-02-26 | DGilbert Cisneros | SELL | $1K – $15K | 8d | receipt → |
| 2025-02-26 | DGilbert Cisneros | SELL | $1K – $15K | 6d | receipt → |
| 2025-01-15 | DJulie Johnson | BUY | $1K – $15K | 28d | receipt → |
| 2024-08-02 | DRo Khanna | BUY | $1K – $15K | 35d | receipt → |
| 2024-07-01 | DRo Khanna | BUY | $1K – $15K | 37d | receipt → |
| 2024-04-30 | RTommy Tuberville | SELL | $50K – $100K | 15d | receipt → |
| 2024-04-30 | RTommy Tuberville | SELL | $50K – $100K | 15d | receipt → |
| 2024-03-21 | RTommy Tuberville | BUY | $15K – $50K | 26d | receipt → |
| 2024-03-21 | RTommy Tuberville | BUY | $15K – $50K | 25d | receipt → |
| 2024-03-25 | DRo Khanna | SELL | $1K – $15K | 11d | receipt → |
| 2024-03-20 | DRo Khanna | SELL | $1K – $15K | 16d | receipt → |
| 2023-07-25 | RTommy Tuberville | BUY | $1K – $15K | 34d | receipt → |
| 2023-06-13 | RTommy Tuberville | BUY | $15K – $50K | 76d | receipt → |
| 2023-06-12 | RTommy Tuberville | BUY | $1K – $15K | 77d | receipt → |
| 2023-05-08 | RTommy Tuberville | BUY | $1K – $15K | 112d | receipt → |
| 2022-01-12 | RTommy Tuberville | BUY | $1K – $15K | 593d | receipt → |